Ellodi Pharmaceuticals, L.P.
Records under this name other than the patents Ellodi Pharmaceuticals, L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
Back to Ellodi Pharmaceuticals, L.P.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,357,750 | Cysteamine Prodrugs now held by Children's Hospital Medical Center Lapsed on the fee record Ended Jun 14, 2026 · High confidence | Lapsed on the fee record | Ended Jun 14, 2026 | High confidence |
| 16/968,711 | Methods of Treating Eosinophilic Esophagitis Abandoned Abandoned May 18, 2024 | Abandoned | Abandoned May 18, 2024 | |
| 16/992,671 | Methods of Treating Eosinophilic Esophagitis Abandoned Abandoned Apr 11, 2024 | Abandoned | Abandoned Apr 11, 2024 | |
| 18/287,416 | Methods of Treating Esophageal Strictures Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/641,910 | Methods of Managing Eosinophilic Esophagitis Abandoned Abandoned Dec 9, 2024 | Abandoned | Abandoned Dec 9, 2024 | |
| 18/755,113 | Methods of Treating Eosinophilic Esophagitis Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/967,539 | Methods of Managing Eosinophilic Esophagitis Abandoned Abandoned Aug 21, 2026 | Abandoned | Abandoned Aug 21, 2026 | |
| 19/170,231 | Orally Administered Corticosteroid Compositions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/179,530 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/403,672 | Orally Administered Corticosteroid Compositions Abandoned Abandoned Oct 31, 2026 | Abandoned | Abandoned Oct 31, 2026 |